MergerLinks Header Logo

Announced

Completed

Enveric Biosciences completed the acquisition of MagicMed Industries.

Synopsis

Enveric Biosciences, a patient-first biotechnology company, completed the acquisition of MagicMed Industries, a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules. Financial terms were not disclosed. "Our proposed acquisition of MagicMed underscores the core fundamental mission of Enveric to form a drug discovery and clinical stage biotechnology company with a focus on bringing forward nature-originated therapies to improve the standard of care and serve unmet needs in oncology and CNS indications," David Johnson, Enveric Biosciences Chairman and CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US